1. Share Prices

  2. Indivior PLC (INDV)

819.00p+4.00 (+0.49%)20 Nov 2024, 12:26
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo
Jump to:

Indivior PLC Fundamentals

Company NameIndivior PLCLast Updated2024-11-20
IndustryDrug Manufacturers - Specialty & GenericSectorHealthcare
Shares in Issue129.917 mMarket Cap£1.06 bn
PE Ratio267.04Dividend per Share0
Dividend Yield0Dividend Cover0
EPS$0.01EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.1940Debt Equity Ratio0
Asset Equity Ratio-8.7665Cash Equity Ratio-1.9042
Quick Ratio0.5915Current Ratio0.83
Price To Book Value0ROCE0

Indivior PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Indivior PLC Company Financials

Assets202320222021
Tangible Assets$117.00 m$85.00 m$95.00 m
Intangible Assets$237.00 m$70.00 m$82.00 m
Investments$41.00 m$98.00 m0
Total Fixed Assets$691.00 m$510.00 m$388.00 m
Stocks$142.00 m$114.00 m$95.00 m
Debtors$254.00 m$220.00 m$202.00 m
Cash & Equivalents$410.00 m$893.00 m$1.10 bn
Other Assets$296.00 m$257.00 m$211.00 m
Total Assets$1.95 bn$1.77 bn$1.83 bn
Liabilities202320222021
Creditors within 1 year$1.30 bn$1.02 bn$804.00 m
Creditors after 1 year$649.00 m$699.00 m$825.00 m
Other Liabilities000
Total Liabilities$1.95 bn$1.72 bn$1.63 bn
Net assets0$51.00 m$203.00 m
Equity202320222021
Called up share capital$68.00 m$68.00 m$70.00 m
Share Premium$18.00 m$14.00 m$10.00 m
Profit / Loss$1.00 m-$95.00 m$190.00 m
Other Equity0$51.00 m$203.00 m
Preference & Minorities000
Total Capital Employed0$51.00 m$203.00 m
Ratios202320222021
Debt Ratio0$0.84$0.58
Debt-to-Equity0$5.22$1.35
Assets / Equity-8.7665-8.7665-8.7665
Cash / Equity-1.9042-1.9042-1.9042
EPS-$0.01-$0.41$1.25
Cash Flow202320222021
Cash from operating activities-$315.00 m-$4.00 m$353.00 m
Cashflow before financing-$361.00 m-$104.00 m$259.00 m
Increase in Cash-$458.00 m-$328.00 m$244.00 m
Income202320222021
Turnover$1.09 bn$901.00 m$791.00 m
Cost of sales$186.00 m$159.00 m$127.00 m
Gross Profit$907.00 m$742.00 m$664.00 m
Operating Profit-$4.00 m-$85.00 m$213.00 m
Pre-Tax profit$1.00 m-$95.00 m$190.00 m

Indivior PLC Company Background

SectorHealthcare
ActivitiesIndivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.
Latest Interim Date25 Jul 2024
Latest Fiscal Year End Date22 Feb 2024

Indivior PLC Directors

AppointedNamePosition
2018-03-22Mr. Cary J ClaiborneExecutive Director,Chief Financial Officer
2019-07-31Mr. Christian Stanton SchadeNon-Executive Director
2019-08-29Ms. Lizabeth Herbst ZlatkusNon-Executive Director
2019-03-29Dr. Yvonne L Greenstreet, MB.Ch.B.Non-Executive Director
2020-09-04Mr. Howard Hao PienNon-Executive Director,Chairman
2016-05-11Mr. Adrian Nevil Hennah Non-Executive Director
2024-07-26Mr. Graham Charles HetheringtonNon-Executive Director,Chairman
2016-10-03Mr. Rupert Mark Boden BondyNon-Executive Director
2020-07-31Ms. Tatjana Anni Hilde MayNon-Executive Director
2022-12-28Mr. Daniel Joseph PhelanNon-Executive Director,Senior Independent Director
2024-07-29Mr. Mark StejbachNon-Executive Director
2024-03-13Dr. Peter James Jonathan Bains Non-Executive Director
2024-03-13Mr. Jerome J LandeNon-Executive Director
2023-09-29Ms. Lorna Mary Southcombe ParkerNon-Executive Director
2021-01-11Mr. Daniel TasseNon-Executive Director,Senior Independent Director
2020-06-29Mr. Shaun ThaxterExecutive Director,Chief Executive Officer
2024-03-13Dr. Andrew Thomas McLellanNon-Executive Director
2024-07-30Ms. Juliet ThompsonNon-Executive Director,Senior Independent Director
2024-07-29Mr. Mark Wesley CrossleyExecutive Director,Chief Executive Officer
2024-07-26Ms. Joanna Susan Le CouilliardNon-Executive Director
2024-03-18Mr. Ryan PreblickExecutive Director,Chief Financial Officer
2024-07-30Mr. Keith Humphreys OBENon-Executive Director

Indivior PLC Contact Details

Company NameIndivior PLC
Address234 Bath Road, Slough, SL1 4EE
Telephone+44 1753217800
Websitehttps://www.indivior.com

Indivior PLC Advisors

Remuneration ConsultantWillis Towers Watson
Phone+44 2071702000
Fax+44 2071702222
SolicitorHerbert Smith Freehills LLP
Phone+44 2073748000
Fax+44 2073740888
Financial PR AdviserTulchan Communications LLP
Phone+44 2073534200
Fax+44 2073534201
Remuneration ConsultantDeloitte LLP
Phone+44 2079363000
Fax+44 2075831198
StockbrokerMorgan Stanley & Co International PLC
Phone+44 2074258000
Fax+44 2074258990
StockbrokerJefferies Hoare Govett
Phone+44 2070298000
Fax+44 2070298010
Financial AdviserJefferies Hoare Govett
Phone+44 2070298000
Fax+44 2070298010
AuditorPricewaterhouseCoopers LLP
Phone+44 2075835000
Fax+44 2078224652
SolicitorSlaughter and May
Phone+44 2076001200
Fax+44 2070905000
RegistrarComputershare Investor Services PLC
Phone+44 3707020003
Fax+44 3707036101
SolicitorCovington & Burling LLP
Phone+44 2070672000
Fax +44 2070672222

Most Read

Receive our
daily news email

Subscribe to the latest investing news by entering your email address below

You can opt out at any time.

For five days a week you will get

  • The latest company news
  • Insight into investment trends
  • Round-up of director's buys and sells
  • Articles from Shares magazine
Sharesmagazine cover

Plus more useful investment content and occasional promotional offers.

Shares Magazine Latest Issue Cover
Latest Issue:
14 Nov 2024Subscribe now

Market Overview

UK 350 Risers and Fallers

Risers

CompanyPrice% Chg
Sage Group PLC1,284.2319.24
Goodwin PLC6,785.604.07
Hill & Smith PLC2,135.002.64
Close Brothers Group PLC203.942.38
Bh Macro Limited386.582.54
Severn Trent PLC2,754.002.42

Fallers

CompanyPrice% Chg
Helios Towers PLC94.20-7.10
Vistry Group PLC624.95-6.79
Dowlais Group PLC51.80-4.25
W.A.G Payment Solutions PLC82.60-3.95
Ssp Group PLC151.00-3.94
Marshalls PLC323.00-3.87